3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
30
Breast Neoplasms
19
Neoplasms
13
Prostatic Neoplasms
10
Obesity
6
Colorectal Neoplasms
6
Sarcopenia
5
Pancreatic Neoplasms
5
Lung Neoplasms
4
Signs and Symptoms
3
Polycystic Ovary Syndrome
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Head and Neck Neoplasms
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Cachexia
2
Weight Loss
1
Uterine Neoplasms
1
Urinary Incontinence
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
fludarabine phosphate
3
Tacrolimus
3
Methotrexate
3
Busulfan
3
Mycophenolic Acid
2
Filgrastim
2
Cyclophosphamide
2
Antilymphocyte Serum
2
merphos
1
Whole-Body Irradiation
1
Resistance Training
1
Pharmacogenomic Testing
1
Oxycodone
1
Ondansetron
1
Mutation
1
Music Therapy
1
Moxifloxacin
1
Morphine
1
Methadone
1
Massage
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Endoscopy, Digestive System
1
Diet, Mediterranean
1
Diagnosis
1
Cytogenetic Analysis
1
Cyclosporine
1
Ciprofloxacin
1
Aprepitant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Thrombocythemia, Essential
×
Resistance Training
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled